La cadena de opciones muestra datos clave de las opciones de acciones de Cue Biopharma a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Cue Biopharma..

Cue Biopharma (NASDAQ:CUE) Bolsa, Cadena de Opciones

Cue Biopharma

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.

Oppenheimer analyst Edward Yang initiates coverage on Camtek (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAMT#NASDAQ">CAMT</a>) with a Outperform rating and announces Price Target of $100.

News

Price Target

Initiation

Analyst Ratings

CAMT

Oppenheimer Initiates Coverage On Camtek with Outperform Rating, Announces Price Target of $100

Western Union's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WU#NYSE">WU</a>) short percent of float has risen 15.11% since its last report. The company recently reported that it has 32.85 million shares sold short, which is 13.03% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.57 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Western Union Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751464832_0_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Western Union has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Western Union's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Western Union's peer group average for short interest as a percentage of float is 6.05%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

Is the Market Bullish or Bearish on Western Union?

During the last three months, 18 analysts shared their evaluations of Rockwell Automation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ROK#NYSE">ROK</a>), revealing diverse outlooks from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">8</td>
<td align="right">6</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">5</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Rockwell Automation, revealing an average target of $310.5, a high estimate of $371.00, and a low estimate of $201.00. Observing a 6.54% increase, the current average has risen from the previous average price target of $291.44. 
<img src="https://www.benzinga.com/files/images/story/2025/1751464832_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Rockwell Automation. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Andrew Obin</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Neutral</td>
<td>$360.00</td>
<td>$330.00</td>
</tr>
<tr>
<td>Joseph O'Dea</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$365.00</td>
<td>$315.00</td>
</tr>
<tr>
<td>Ken Newman</td>
<td>Keybanc</td>
<td>Raises</td>
<td>Overweight</td>
<td>$360.00</td>
<td>$345.00</td>
</tr>
<tr>
<td>Andrew Kaplowitz</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$371.00</td>
<td>$327.00</td>
</tr>
<tr>
<td>Julian Mitchell</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$350.00</td>
<td>$283.00</td>
</tr>
<tr>
<td>Ken Newman</td>
<td>Keybanc</td>
<td>Raises</td>
<td>Overweight</td>
<td>$345.00</td>
<td>$330.00</td>
</tr>
<tr>
<td>Stephen Tusa</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$299.00</td>
<td>$271.00</td>
</tr>
<tr>
<td>Chris Dankert</td>
<td>Loop Capital</td>
<td>Raises</td>
<td>Hold</td>
<td>$290.00</td>
<td>$280.00</td>
</tr>
<tr>
<td>Andrew Kaplowitz</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$327.00</td>
<td>$283.00</td>
</tr>
<tr>
<td>Julian Mitchell</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$283.00</td>
<td>$260.00</td>
</tr>
<tr>
<td>Ken Newman</td>
<td>Keybanc</td>
<td>Raises</td>
<td>Overweight</td>
<td>$330.00</td>
<td>$275.00</td>
</tr>
<tr>
<td>Noah Kaye</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$304.00</td>
<td>$258.00</td>
</tr>
<tr>
<td>Joseph O'Dea</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$315.00</td>
<td>$265.00</td>
</tr>
<tr>
<td>Stephen Tusa</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$271.00</td>
<td>$201.00</td>
</tr>
<tr>
<td>Andrew Kaplowitz</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$283.00</td>
<td>$350.00</td>
</tr>
<tr>
<td>Julian Mitchell</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$260.00</td>
<td>$280.00</td>
</tr>
<tr>
<td>Stephen Tusa</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$201.00</td>
<td>$248.00</td>
</tr>
<tr>
<td>Ken Newman</td>
<td>Keybanc</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$275.00</td>
<td>$345.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Rockwell Automation. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Rockwell Automation compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Rockwell Automation's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
To gain a panoramic view of Rockwell Automation's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/ROK/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Rockwell Automation analyst ratings.</a>
<h2>About Rockwell Automation</h2>
With roots tracing back to the early 1900s, Rockwell Automation is the successor to Rockwell International, which spun off its avionics segment in 2001. It is a pure-play industrial automation company that operates through three segments. Its largest segment by revenue, intelligent devices, sells factory floor-level devices such as motors, drives, sensors, relays, and actuators. Its software and control segment sells visualization, simulation, and human-machine interface software and control products such as programmable controllers, computers, and operator terminals. Its smallest segment, lifecycle services, offers digital consulting, engineered-to-order services, and other outsourced services such as remote monitoring, cybersecurity, and asset and plant maintenance and optimization.
<h3>Rockwell Automation's Financial Performance</h3>
Market Capitalization Analysis: The company's market capitalization is above the industry average, indicating that it is relatively larger in size compared to peers. This may suggest a higher level of investor confidence and market recognition.
Negative Revenue Trend: Examining Rockwell Automation's financials over 3M reveals challenges. As of 31 March, 2025, the company experienced a decline of approximately -5.88% in revenue growth, reflecting a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Industrials sector.
Net Margin: Rockwell Automation's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 12.54%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Rockwell Automation's ROE excels beyond industry benchmarks, reaching 7.36%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Rockwell Automation's ROA excels beyond industry benchmarks, reaching 2.29%. This signifies efficient management of assets and strong financial health.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 1.19, caution is advised due to increased financial risk.
<h2>Analyst Ratings: Simplified</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Rockwell Automation Stock: A Deep Dive Into Analyst Perspectives (18 Ratings)

Element Solutions's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESI#NYSE">ESI</a>) short percent of float has fallen 19.6% since its last report. The company recently reported that it has 4.95 million shares sold short, which is 2.83% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.25 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Element Solutions Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751464826_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Element Solutions has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Element Solutions's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Element Solutions's peer group average for short interest as a percentage of float is 4.63%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Looking Into Element Solutions's Recent Short Interest

During the last three months, 4 analysts shared their evaluations of Enterprise Prods Partners (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EPD#NYSE">EPD</a>), revealing diverse outlooks from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $35.5, a high estimate of $36.00, and a low estimate of $35.00. Observing a downward trend, the current average is 2.07% lower than the prior average price target of $36.25. 
<img src="https://www.benzinga.com/files/images/story/2025/1751464822_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
A comprehensive examination of how financial experts perceive Enterprise Prods Partners is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Theresa Chen</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$35.00</td>
<td>$36.00</td>
</tr>
<tr>
<td>Brandon Bingham</td>
<td>Scotiabank</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$36.00</td>
<td>$35.00</td>
</tr>
<tr>
<td>Theresa Chen</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$36.00</td>
<td>$37.00</td>
</tr>
<tr>
<td>Spiro Dounis</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$35.00</td>
<td>$37.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Enterprise Prods Partners. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Enterprise Prods Partners compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Enterprise Prods Partners's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Enterprise Prods Partners's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/EPD/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Enterprise Prods Partners analyst ratings.</a>
<h2>About Enterprise Prods Partners</h2>
Enterprise Products Partners is a master limited partnership that transports and processes natural gas, natural gas liquids, crude oil, refined products, and petrochemicals. It is one of the largest midstream companies, with operations servicing most producing regions in the continental US. Enterprise is particularly dominant in the NGL market and is one of the few MLPs that provide midstream services across the full hydrocarbon value chain.
<h3>Unraveling the Financial Story of Enterprise Prods Partners</h3>
Market Capitalization Analysis: With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.
Revenue Growth: Enterprise Prods Partners's remarkable performance in 3M is evident. As of 31 March, 2025, the company achieved an impressive revenue growth rate of 4.45%. This signifies a substantial increase in the company's top-line earnings. When compared to others in the Energy sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: Enterprise Prods Partners's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of 8.95%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Enterprise Prods Partners's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 4.79% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Enterprise Prods Partners's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.81% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: Enterprise Prods Partners's debt-to-equity ratio is below the industry average at 1.09, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>The Basics of Analyst Ratings</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Demystifying Enterprise Prods Partners: Insights From 4 Analyst Reviews

Gartner's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IT#NYSE">IT</a>) short percent of float has risen 30.16% since its last report. The company recently reported that it has 2.64 million shares sold short, which is 3.97% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.51 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Gartner Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751464821_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Gartner has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Gartner's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Gartner's peer group average for short interest as a percentage of float is 4.71%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

How Is The Market Feeling About Gartner?

In the current market session, Western Digital Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WDC#NASDAQ">WDC</a>) stock price is at $63.80, after a 0.06% drop. However, over the past month, the company's stock went up by 17.40%, and in the past year, by 9.62%. Shareholders might be interested in knowing whether the stock is overvalued, even if the company is not performing up to par in the current session. 

<img src="https://www.benzinga.com/files/images/story/2025/1751464818_0.png" alt="Past Year Chart" />

<h3>Western Digital P/E Compared to Competitors</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
Western Digital has a lower P/E than the aggregate P/E of 28.59 of the Technology Hardware, Storage &amp; Peripherals industry. Ideally, one might believe that the stock might perform worse than its peers, but it's also probable that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1751464818_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

Markets

Price Over Earnings Overview: Western Digital

ESGRO

Trading Halt: Halt status updated at 10:00:00 AM ET: Quotation Resumption: News and Resumption Times

UnitedHealth Group Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) shares are moving lower Wednesday in sympathy with Centene, which <a href="https://www.benzinga.com/markets/guidance/25/07/46209736/centene-withdraws-2025-guidance-shares-dive">withdrew its 2025 guidance</a>. 
What Happened: Late Tuesday, health insurer Centene warned that it expects earnings to come up short of prior expectations. The company withdrew its 2025 earnings per share guidance as a result.
Centene said that overall market growth in 22 of the company's 29 marketplace states was lower than previously expected based on the company's preliminary interpretation of marketplace data from independent actuarial firm Wakely.&nbsp;
Centene forecasted an estimated reduction of its previous full-year net risk adjustment revenue transfer&nbsp;expectations of approximately $1.8 billion, representing an adjusted earnings impact of approximately $2.75 per share.
United Health and other health insurer stocks moved lower alongside Centene. In May, United Health <a href="https://www.benzinga.com/25/05/45373368/unitedhealth-stock-plunges-names-new-ceo-suspends-2025-guidance">suspended</a> its 2025 guidance as care activity accelerated and broadened to more types of benefit offerings and medical costs remained higher than the company expected. 
Shares of Elevance and Humana were also moving lower at last check, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
United Health shares are down approximately 35% year-to-date amid rising medical costs. The company said on an earnings call earlier this year that even common procedures can cost up to four times more in the U.S. than in other countries.
CEO Andrew Witty stepped down as CEO in May and was replaced by Stephen Hemsley, who previously held the CEO role from 2006 to 2017. United Health has said it expects to return to growth in 2026. 
UNH Price Action: <a href="http://benzinga.com/quote/UNH">United Health shares</a> were down 2.18% at $319.02 at the time of publication Wednesday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/health-care/25/06/46056665/unitedhealth-cvs-among-major-insurers-to-fast-track-prior-authorizations-will-it-cut-profits-even-more">UnitedHealth, CVS Among Major Insurers To Fast-Track Prior Authorizations: Will It Cut Profits Even More?</a></li>
</ul>
Photo: Ken Wolter/Shutterstock.com

Movers

United Health Stock Is Sliding Today: What's Going On?

RBC Capital analyst Steven Shemesh reiterates O'Reilly Automotive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORLY#NASDAQ">ORLY</a>) with a Outperform and maintains $98 price target.

Reiteration

ORLY

RBC Capital Reiterates Outperform on O'Reilly Automotive, Maintains $98 Price Target

DAIC

CID HoldCo Shares Resume Trade

Stellantis N.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STLA#NYSE">STLA</a>) shares are trading relatively flat on Wednesday, following a batch of mixed news, including a federal investigation, solid brand <a target="_blank" href="https://www.benzinga.com/movers" rel="noreferrer noopener">performance, and a corporate update</a>.
The company is facing a federal recall <a target="_blank" href="https://static.nhtsa.gov/odi/inv/2025/INOA-RQ25002-13790.pdf" rel="noreferrer noopener">probe</a> by the U.S. National Highway Traffic Safety Administration (NHTSA) concerning nearly 299,000 Stellantis vehicles.
The investigation, known as Recall Query RQ25002, is focused on gear shifter cable bushings, which could deteriorate and detach, potentially causing the transmission to remain in an unintended gear despite the shifter appearing normal. This poses a risk of the vehicle rolling away if the driver exits without it being in PARK.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/tech/25/06/45945138/stellantis-trials-new-5-minute-battery-swapping-tech-in-fiat-500e-fleet-report" rel="noreferrer noopener">Stellantis Trials New 5-Minute Battery Swapping Tech In Fiat 500e Fleet: Report</a>
This issue was previously addressed in a 2019 recall (19V-293) for 2013–2016 Dodge Dart vehicles, but 44 complaints of recurring problems prompted the new probe to assess the effectiveness of the prior fix and explore other potential causes.
In corporate news, the company announced it will report its first-half 2025 <a target="_blank" href="https://www.benzinga.com/pressreleases/25/07/g46217299/stellantis-to-announce-first-half-2025-results-on-july-29" rel="noreferrer noopener">financial results on Tuesday, July 29.</a>
In a separate release, Stellantis said FCA US reported a total of 309,973 vehicles sold in the U.S. during the second quarter of 2025, <a target="_blank" href="https://www.benzinga.com/pressreleases/25/07/n46210551/fca-us-reports-second-quarter-2025-us-sales-results" rel="noreferrer noopener">down 10% from the prior year</a>.
However, the Ram and Jeep brands showed strength, with the Ram 1500, ProMaster van, and Jeep Wrangler among the standout performers.
The Ram brand reported a 5% quarterly sales increase, led by a 17% boost in Ram 1500 deliveries. Jeep Wrangler sales climbed 23% year over year, while the plug-in hybrid 4xe variant recorded its best April since launch.
From the first quarter to the second quarter, Ram sales rose 18%, and Jeep Wrangler sales jumped 26%. Jeep Gladiator, Grand Cherokee, and Compass models also posted sequential growth.
The company noted over 10,000 orders in just one day following the return of the HEMI V-8 engine to Ram&#8217;s lineup.
Year-to-date, Ram retail sales rose 25%, while Jeep and Dodge also delivered gains. Fiat saw notable growth, with Fiat 500e sales up 286% compared to the first half of 2024.
With fresh marketing campaigns tied to upcoming blockbuster films and a new powertrain warranty for Ram vehicles, Stellantis appears to be positioning its portfolio for continued engagement.
Additionally, the Chrysler brand is celebrating its 100th anniversary with special edition releases and events.
According to&nbsp;<a target="_blank" href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" rel="noreferrer noopener">Benzinga Pro</a>, STLA stock has lost over 48% in the past year.
Price Action: STLA shares are trading lower by 0.05% to $10.22 at last check Wednesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/economic-data/25/07/46218795/labor-market-payrolls-june-interest-rates" target="_blank" rel="noreferrer noopener">Labor Market Flashes Red Signal—And The Last Time This Happened It Didn&#8217;t End Well</a></li>
</ul>
Image by rikstock via Shutterstock

Equities

General

STLA

Stellantis Under New Federal Recall Investigation For Gear Shifter Issue

Cipher Mining Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CIFR#NASDAQ">CIFR</a>) shares are trading higher. The company on Wednesday provided an update on its Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) <a href="https://www.benzinga.com/pressreleases/25/07/g46216046/cipher-mining-surpasses-hashrate-growth-forecasts-at-black-pearl-and-announces-june-2025-operation">mining operations for June</a>.
What To know: Cipher said it produced 160 Bitcoin last month and sold 58, ending June with total Bitcoin holdings of approximately 1,063. 
The miner had an operating hashrate of 16.8 EH/s as of the end of the month. Cipher Mining also announced that the first phase of its Black Pearl site is currently delivering approximately 3.4 EH/s of self-mining capacity, versus the company&#8217;s prior guidance of 2.5 EH/s for the second quarter. 
Cipher said it expects its hashrate to continue to increase at the site through the&nbsp;third quarter&nbsp;as new mining rigs are delivered. The company anticipates scaling its hashrate to about 23.1 EH/s upon completion of the installation.
<h3 class="wp-block-heading">How To Buy CIFR Stock</h3>
By now you're likely curious about how to participate in the market for Cipher Mining &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy &#8220;fractional shares,&#8221; which allows you to own portions of stock without buying an entire share.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to &#8220;go short&#8221; a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
CIFR Price Action: <a href="http://benzinga.com/quote/CIFR">Cipher Mining shares</a> were up 8.57% at $5.32 at the time of publication Wednesday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46215827/bitcoins-halving-cycle-is-over-standard-chartered-affirms-what-that-means-for-you">Bitcoin&#8217;s Halving Cycle Is &#8216;Over&#8217;, Standard Chartered Affirms: What That Means For You</a></li>
</ul>
Photo: Wirestock Creators/Shutterstock.com

$BTC

CIFR

What's Going On With Bitcoin Mining Stock Cipher (CIFR) Wednesday?

With President Trump's &#8220;<a href="https://www.benzinga.com/news/financing/25/07/46215975/trumps-big-beautiful-bill-offers-seniors-a-6000-bonus-tax-deduction-heres-how-you-qualify-for-the-">One Big Beautiful Bill</a>&#8221; narrowly passing the Senate, market watchers say the broader economic fallout could create tailwinds for Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) and digital assets, even as direct crypto measures were left out of the legislation.
What Happened: Santiment <a href="https://x.com/santimentfeed/status/1940150509283020800">data</a> points out how the Big Beautiful Bill passing may be bullish for cryptocurrencies. 
Though the bill contained no specific crypto provisions, traders and analysts are focused on its economic ripple effects: large tax cuts and bonus depreciation may benefit Bitcoin miners, rising Treasury issuance could prompt Fed easing, injecting liquidity into markets and there's a possibility of looser monetary conditions if debt pressures mount.
Analytics firm Santiment noted that the bill could revive investor appetite for digital assets, with $107,000 BTC eventually seen as a bargain entry once broader bullish sentiment returns.
Also Read: <a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46218075/bitcoin-climbs-while-ethereum-xrp-dogecoin-stay-flat-as-big-beautiful-bill-resolution-nears">Bitcoin Climbs While Ethereum, XRP, Dogecoin Stay Flat As &#8216;Big Beautiful Bill&#8217; Resolution Nears</a>
Why It Matters: The bill's exclusion of Senator Cynthia Lummis' (R-Wyo.) crypto tax amendment, which aimed to address taxation issues for staking, mining, and micro transactions, was a letdown for the industry. Still, the macro backdrop remains favourable for crypto.
Nic Puckrin, founder of CoinBureau, believes the bill will accelerate dollar devaluation by adding $3.3 trillion to U.S. debt. 
The U.S. Dollar Index (DXY) has already logged its worst start to the year since 1973, signalling weakening fiat sentiment, typically bullish for Bitcoin as a hedge.
Puckrin emphasized that while Fed Chair Jerome Powell remains cautious, growing pressure from Trump and some FOMC members to slash rates, possibly to 1%, could soon force a pivot. 
He believes once the rate cuts arrive, liquidity will flood markets, and Bitcoin's bull run will ignite, with current prices offering deep value.
What's Next: Markets may be experiencing a brief "sell-the-rumour, buy-the-news" reaction, but traders expect momentum to shift as the House votes and macro conditions evolve. 
In Puckrin's words, the bill "sets the stage for a macro-driven Bitcoin expansion," and once dust settles, the crypto market could see explosive upside.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46217148/heres-why-altcoin-season-for-xrp-eth-sol-has-not-happened-yet">Here&#8217;s Why &#8216;Altcoin Season&#8217; For XRP, ETH, SOL Has Not Happened Yet</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

How Trump's 'Big Beautiful Bill' Could Create A 'Big Beautiful Bull Run' For Bitcoin, Ethereum, XRP

CID HoldCo Shares Halted On Circuit Breaker To The Upside, Stock Now Up 149%

Aeries Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AERT#NASDAQ">AERT</a>) affirms FY2026 sales outlook from $74.000 million-$80.000 million to $74.000 million-$80.000 million.

Guidance

Advanced Environmental Recycling Technologies

AERT

Aeries Technology Affirms FY2026 Sales Guidance of $74.000M-$80.000M

Northland Capital Markets analyst Gus Richard downgrades Quanta Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PWR#NYSE">PWR</a>) from Outperform to Market Perform and maintains the price target from $354 to $354.

Downgrades

Northland Capital Markets Downgrades Quanta Services to Market Perform, Maintains Price Target to $354

ONCHU

Trading Halt: Halt status updated at 9:50:00 AM ET: Quotation Resumption: IPO Security - Released for Quotation

MSFT

Reuters Cites Company Spokesperson Saying Microsoft's Latest Round Of Layoffs To Impact Less Than 4% Of Total Workforce

MSC Industrial Direct Co. Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSM#NYSE">MSM</a>) posted better-than-expected financial results for i<a href="https://www.benzinga.com/quote/MSM/earnings">ts fiscal third quarter of 2025 on Tuesday.</a>
Net sales slipped 0.8% year over year to $971.1 million but edged past the consensus estimate of $970.23 million. The company reported adjusted earnings per share of $1.08, down 18.8% year over year, topping analysts&#8217; expectations of $1.03.
"The fiscal third quarter included encouraging data points, such as core customer sequential improvement, continued momentum in our high-touch solutions and a building productivity pipeline. Looking longer term, we remain steadfast in our commitment to restoring performance consistent with our long-term objectives of growing to 400 basis points or more above the IP Index and expanding operating margins to the mid-teens," commented Erik Gershwind, Chief Executive Officer.
MSC expects fourth-quarter average daily sales to range from a decline of 0.5% to a gain of 1.5%, with an adjusted operating margin of 8.5% to 9%. For fiscal year 2025, the company expects a free cash flow conversion of ~120% and capital expenditures of ~$100 million-$110 million.
MSC shares fell 0.8% to trade at $89.53 on Wednesday.
These analysts made changes to their price targets on MSC following earnings announcement.
<ul class="wp-block-list">
<li>Stephens &amp; Co. analyst Tommy Moll maintained MSC Industrial Direct with an Equal-Weight rating and raised the price target from $85 to $90.</li>
<li>Baird analyst David Manthey maintained the stock with a Neutral and raised the price target from $84 to $95.</li>
<li>Loop Capital analyst Chris Dankert maintained MSC Industrial Direct with a Hold and raised the price target from $74 to $84.</li>
</ul>
Considering buying MSM stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><a href="https://www.benzinga.com/quote/MSM/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="622" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/02094737/image-30-1024x622.png" alt="" class="wp-image-970470" style="width:652px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/02094737/image-30-1024x622.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/02094737/image-30-300x182.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/02094737/image-30-768x467.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/02094737/image-30.png 1106w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/dividends/25/07/46216643/wall-streets-most-accurate-analysts-give-their-take-on-3-financial-stocks-delivering-high-dividend-yields-4">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Financial Stocks Delivering High-Dividend Yields</a> </li>
</ul>
Photo via Shutterstock

Earnings

MSC Industrial Direct Analysts Boost Their Forecasts After Upbeat Q3 Results

Press Releases

Cue Biopharma Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights

Health Care

Boehringer Ingelheim and Cue Biopharma partner to develop next-generation treatment for autoimmune and inflammatory diseases

Cue Biopharma to Host Business Update Call and Webcast

Cue Biopharma Announces Proposed Public Offering

IPOs

Cue Biopharma Announces Pricing of Approximately $20 Million Public Offering

Cue Biopharma to Participate in Fireside Chat at the Citizens Life Sciences Conference

Cue Biopharma to Host Virtual Investor Event on May 15, 2025

Cue Biopharma Reports First Quarter 2025 Financial Results and Recent Business Highlights

Cue Biopharma Receives FDA Feedback on Pre-IND Briefing Document Reinforcing Company's Intention to Advance IND Submission for CUE-401 to Address Unmet Need in the Treatment of Autoimmune Disease

Cue Biopharma Provides Update on Most Advanced Clinical Stage Asset, CUE-101, Presented by Dr. Dimitrios Colevas at the DAVA 4th Hawaii Global Summit on Thoracic Malignancies

Comments

Cue Biopharma

Cue Biopharma (CUE) Opciones

Cue Biopharma (NASDAQ:CUE) Bolsa, Cadena de Opciones

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL